IRIS
CHIAPPINI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.582
AS - Asia 1.149
EU - Europa 672
SA - Sud America 213
AF - Africa 27
OC - Oceania 3
Totale 3.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.513
SG - Singapore 545
CN - Cina 214
BR - Brasile 178
IT - Italia 173
VN - Vietnam 142
DE - Germania 122
RU - Federazione Russa 110
BD - Bangladesh 107
IE - Irlanda 62
SE - Svezia 40
CA - Canada 34
HK - Hong Kong 33
FI - Finlandia 32
IN - India 32
MX - Messico 28
GB - Regno Unito 26
FR - Francia 20
AT - Austria 17
AR - Argentina 16
NL - Olanda 15
ES - Italia 14
PL - Polonia 13
KR - Corea 12
ZA - Sudafrica 10
LT - Lituania 9
TR - Turchia 9
JP - Giappone 8
IQ - Iraq 7
UZ - Uzbekistan 7
EC - Ecuador 6
MA - Marocco 5
EG - Egitto 4
HU - Ungheria 4
PK - Pakistan 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
ID - Indonesia 3
IL - Israele 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
JO - Giordania 2
KZ - Kazakistan 2
MN - Mongolia 2
NP - Nepal 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TW - Taiwan 1
UY - Uruguay 1
Totale 3.646
Salva come PNG Salva come JPEG
Città #
Singapore 417
San Jose 318
Ashburn 194
Council Bluffs 111
Munich 85
Dallas 77
Dublin 62
The Dalles 61
Beijing 58
Los Angeles 55
Chandler 54
Ho Chi Minh City 46
New York 45
Santa Clara 39
São Paulo 36
Hong Kong 28
Rome 25
Hanoi 24
Buffalo 22
Orem 19
Princeton 19
Hefei 18
Redondo Beach 18
Tongling 18
Chennai 15
Denver 15
Milan 15
Montreal 15
Washington 14
Boardman 13
St Louis 13
Turku 13
Atlanta 12
Frankfurt am Main 12
Warsaw 12
Helsinki 11
Toronto 11
Da Nang 10
Düsseldorf 10
Moscow 10
San Francisco 10
Houston 9
Memphis 9
Nuremberg 9
Altamura 8
Boston 8
Chicago 8
Guangzhou 8
Johannesburg 8
Lappeenranta 8
Mexico City 8
Tokyo 8
Vienna 8
Amsterdam 7
Seoul 7
Brooklyn 6
Haiphong 6
Lauterbourg 6
Phoenix 6
Silvi 6
Tashkent 6
Ankara 5
Mumbai 5
Stockholm 5
Augusta 4
Baghdad 4
Campinas 4
Gwangju 4
Hải Dương 4
Manchester 4
New Delhi 4
Phủ Lý 4
Portsmouth 4
Querétaro 4
Seattle 4
Bari 3
Belo Horizonte 3
Budapest 3
Bắc Giang 3
Camerino 3
Can Tho 3
Charleston 3
City of London 3
Curitiba 3
Hangzhou 3
London 3
Milwaukee 3
Norfolk 3
Paris 3
Philadelphia 3
Poplar 3
Porto Alegre 3
Rio de Janeiro 3
San Benedetto del Tronto 3
Scandicci 3
Turin 3
Xiamen 3
Asunción 2
Baku 2
Bismarck 2
Totale 2.340
Salva come PNG Salva come JPEG
Nome #
Over-the-counter Psychosis: A Systematic Review of the Misuse of Antihistamines, Cough Medicines, and Decongestants and the Risk of Developing Psychosis 154
Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review 144
Misuse of Anticholinergic Medications: A Systematic Review 110
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 110
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report 107
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 104
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 101
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 98
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 96
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 95
Climate change, biodiversity loss and mental health: a global perspective 95
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 95
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 92
Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation 92
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 92
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 91
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 90
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 88
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 86
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 86
New psychoactive substances and suicidality: A systematic review of the current literature 86
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 85
Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain 85
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances 84
Brexpiprazole as a new approach of treatment in somatization disorder 84
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 82
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 79
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 77
Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review 75
Opioid painkiller dependence in a sample of elderly medical inpatients 74
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial 73
Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study 70
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature 63
Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 63
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 61
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia 60
The benzydamine experience: a systematic review of benzydamine abuse 60
Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study 59
Emerging strategies and clinical recommendations for the management of novel depression subtypes 55
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 54
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality 49
Clinical Management of Synthetic-Cannabinoid-Induced Psychosis: A Systematic Review of Treatment Strategies and Outcomes 25
Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature 23
Alcohol vs. Cocaine: Impulsivity and Alexithymia in Substance Use Disorder 21
Exploring Dual Diagnoses: Psychopathological Characteristics in the Co-Occurrence of Schizophrenia and Addiction – A Scoping Review 19
Eco-Anxiety and Mental Health: Correlates of Climate Change Distress 19
Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia 18
Anomalous self-experience in schizophrenia spectrum disorders: Phenomenological and psychopathological correlates 16
Semaglutide for Craving Reduction in a Cocaine Dependent Patient: A Case Report 15
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database 14
Cannabis use and psychotic-like experiences: A systematic review of biological vulnerability, potency effects, and clinical trajectories 14
Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data 13
Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective 13
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes 12
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study 12
Novel psychoactive substances and psychosis: A comprehensive systematic review of epidemiology, clinical features, neurobiology, and treatment 12
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy 8
Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literature 7
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor 5
Totale 3.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 1 0 0 0 9 2 11 1 18
2022/2023199 9 25 12 10 19 37 11 17 45 4 2 8
2023/2024250 11 18 34 12 29 52 25 10 11 14 5 29
2024/2025724 60 88 51 16 27 16 32 23 69 91 125 126
2025/20262.545 174 101 174 286 236 112 275 194 287 241 335 130
Totale 3.770